Aptose Biosciences Inc (NAS:APTO)
$ 0.3737 0.0123 (3.4%) Market Cap: 6.62 Mil Enterprise Value: -1.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q4 2018 Aptose Biosciences Inc Earnings Call Transcript

Mar 12, 2019 / 09:00PM GMT
Release Date Price: $26.1 (+5.45%)
Operator

Good afternoon. My name is Dilem, and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences Conference Call for the Fourth Quarter and Year ended December 31, 2018. (Operator Instructions) As a reminder, this conference call may be recorded.

I would now like to introduce Susan Pietropaolo. Please go ahead.

Susan M. Pietropaolo
SMP Communications, Inc. - Principal

Thank you, Dilem. Good morning, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the fourth quarter and year ended December 31, 2018. I am Susan Pietropaolo, a communications representative for Aptose Biosciences. Joining me on the call today are Dr. William G. Rice, Chairman, President and CEO; and Mr. Gregory Chow, Senior Vice President and Chief Financial Officer.

Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and Canadian securities laws. Forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot